Novo Nordisk A/S
CNBC Daily Open: Inflation and dot plots
A person shops at a Whole Foods Market grocery store on December 17, 2024 in New York City. Spencer Platt | Getty Images This report is from today’s CNBC Daily Open, our international markets newsletter. CNBC Daily Open brings investors up to speed on everything they need to know, no matter where they are. Like […]
Read More
CNBC Daily Open: With cooler-than-expected PCE, would the Fed’s dot plot have looked different?
A customer, holding a carton of eggs at a supermarket, in United States on Dec. 20, 2024. Secuk Ancar | Anadolu | Getty Images This report is from today’s CNBC Daily Open, our international markets newsletter. CNBC Daily Open brings investors up to speed on everything they need to know, no matter where they are. […]
Read More
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea, expanding use in U.S.
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March 28, 2024. Shelby Knowles | Bloomberg | Getty Images The Food and Drug Administration approved Eli Lilly‘s blockbuster weight loss drug Zepbound for treating patients with the most common sleep-related breathing disorder, the drugmaker announced […]
Read More
Stocks making the biggest moves midday: Novo Nordisk, Mission Produce, Occidental Petroleum and more
Check out the companies making headlines in midday trading: JPMorgan , Bank of America , Wells Fargo — The three U.S. banks that dominate transactions on the Zelle payments network all rose around 2% despite a Friday lawsuit from the Consumer Financial Protection Bureau over Zelle payment fraud. Crypto-linked stocks — Shares of MicroStrategy , […]
Read More
Stocks making the biggest moves premarket: Novo Nordisk, FedEx, Nike, Starbucks, MicroStrategy and more
Check out the companies making headlines before the bell. Novo Nordisk – Shares plunged more than 19% after the Danish pharmaceutical giant reported disappointing late-stage trial results for its experimental weight loss drug, CagriSema. Rival obesity drug maker Eli Lilly rose more than 6% following the results. FedEx – Shares jumped 8.5% after FedEx announced […]
Read More
Novo Nordisk shares plunge 19% after disappointing trial results; Lilly jumps in premarket
Boxes of Ozempic and Wegovy made by Novo Nordisk are seen at a pharmacy. Hollie Adams | Reuters Shares of Danish pharmaceutical giant Novo Nordisk plummeted more than 24% at one point on Friday after reporting results in a late-stage trial for its experimental CagriSema weight loss drug that missed expectations. The maker of the […]
Read More
Merck to develop weight loss pill from Chinese drugmaker in up to $2 billion licensing deal
Exterior view of the entrance to Merck headquarters on February 05, 2024 in Rahway, New Jersey. Spencer Platt | Getty Images Merck on Wednesday said it has snagged the rights to an experimental weight loss pill from Chinese drugmaker Hansoh Pharma, in a deal worth up to $2 billion. The oral drug has not yet […]
Read More
Europe’s economy faces a bumpy ride in 2025. Here are 5 things to watch
For the price of a 500 square foot apartment in NYC, you can get a property over 2,000 square feet in Madrid, Spain, according to My Dolce Casa. Alexander Spatari | Moment | Getty Images Between political upheaval, some weak economic data and warnings about falling short of its growth potential, Europe’s had a tough […]
Read More
Healthy Returns: Novo Nordisk’s Ozempic faces scrutiny over potential link to rare eye condition
A box of Ozempic made by Novo Nordisk is seen at a pharmacy in London, Britain March 8, 2024. Hollie Adams | Reuters A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. There may be a […]
Read More
Healthy Returns: A huge deal to boost Novo Nordisk’s manufacturing is one step closer to closing
A view of the logo of Novo Nordisk at the company’s office in Bagsvaerd, on the outskirts of Copenhagen, Denmark, March 8, 2024. Tom Little | Reuters A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. […]
Read More